A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. van de Wyngaert FA, Beguin C, D'hooghe M, Dooms G, Lissoir F, Carton H, Sindic CJ Acta Neurol Belg. 2001 Dec; 101(4):210-6. PMID: 11851027. Abstract CommentRecommendBookmarkWatch
